ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $210,590 | -68.1% | 13,228 | -67.3% | 0.01% | -74.4% |
| Q3 2022 | $661,000 | +130.3% | 40,394 | +98.2% | 0.04% | +200.0% |
| Q2 2022 | $287,000 | -41.9% | 20,383 | 0.0% | 0.01% | -35.0% |
| Q1 2022 | $494,000 | -4.6% | 20,383 | -8.1% | 0.02% | +11.1% |
| Q4 2021 | $518,000 | +100.8% | 22,186 | +43.0% | 0.02% | +125.0% |
| Q3 2021 | $258,000 | +214.6% | 15,515 | +386.7% | 0.01% | +300.0% |
| Q1 2021 | $82,000 | -85.2% | 3,188 | -69.3% | 0.00% | -83.3% |
| Q4 2020 | $554,000 | +78.7% | 10,369 | +38.0% | 0.01% | +71.4% |
| Q3 2020 | $310,000 | +109.5% | 7,516 | +145.5% | 0.01% | +133.3% |
| Q2 2020 | $148,000 | -81.7% | 3,062 | -84.0% | 0.00% | -84.2% |
| Q1 2020 | $807,000 | -12.3% | 19,102 | -11.2% | 0.02% | -9.5% |
| Q4 2019 | $920,000 | +43.5% | 21,506 | +20.7% | 0.02% | +40.0% |
| Q3 2019 | $641,000 | +21.6% | 17,821 | -9.7% | 0.02% | +25.0% |
| Q2 2019 | $527,000 | – | 19,732 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |